NTRR and S2O2 Break Into Booming Colorado Cannabis Sector With New LOI

TAMPA, Fla.--()--Breakthrough horticultural products being marketed to Colorado’s booming cannabis cultivation industry by Neutra Corp. (OTCBB:NTRR) and its joint venture partner Surface to Air Solutions (S2O2) will soon be put into use by one of the state’s top growers after a new letter of intent was signed last week.

S2O2 inked the letter of intent with DANK Dispensaries and Denver Consulting Group, premiere U.S. cannabis producers, to test and demonstrate the efficacy of its horticultural product suite at the company’s indoor growing operations in the state. By verifying its products’ use in eliminating contaminants from plants, surfaces and air inside growing facilities, the joint venture plans to take the first step toward making them industry-standard across the entire cannabis sector.

"DANK is one of the most established and respected growers in Colorado,” said NTRR CEO Chris Brown. “We knew we had to start at the top to be taken seriously, so we’re extremely thrilled to be working with them. We’re expecting dramatic results, and we think they’ll be very pleased.”

According to the letter of intent, S2O2’s antimicrobial surface treatment, nutritional plant tonic and air-scrubbing hydroxyl generator will be tested at DANK’s facilities for three months. NTRR and S2O2 plan to announce a letter of intent with a third-party lab to conduct the testing in the coming days.

NTRR formed the joint venture with S2O2 last year to market novel and ideal solutions to growers that are concerned about contamination of their crops by microbes, molds, fungus and other pests.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (OTCBB:GWPRF), INSYS Therapeutics, Inc. (NASDAQ:INSY) and ENDEXX Corp. (OTCBB:EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contacts

Neutra Corp.
Chris Brown, 813-367-2041
President and CEO
info@neutracorp.com

Release Summary

NTRR and S2O2 Break Into Booming Colorado Cannabis Sector With New LOI

Contacts

Neutra Corp.
Chris Brown, 813-367-2041
President and CEO
info@neutracorp.com